+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024 - Product Thumbnail Image

5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Leukotriene D4 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2024
  • 145 Pages
  • Global
From
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2024 - Product Thumbnail Image

Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032

  • Drug Pipelines
  • January 2024
  • 136 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 106 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 212 Pages
  • Global
From
Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast- 2034 - Product Thumbnail Image

Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast- 2034

  • Report
  • January 2024
  • 72 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 182 Pages
  • Global
From
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 182 Pages
  • Global
From
Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 184 Pages
  • Global
From
Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 181 Pages
  • Global
From
Levofloxacin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Levofloxacin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 188 Pages
  • Global
From
Acute Lung Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Acute Lung Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Cystic Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034 - Product Thumbnail Image

Cystic Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

  • Report
  • May 2024
  • 137 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis (IPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis (IPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

  • Report
  • May 2024
  • 135 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more